ClinicalTrials HQ

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

Active, not recruiting · NCT05004064 · Registry updated 2026-06-22
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasmActive, not recruitingPhase 22026-06-22NCT05004064

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
AstraZeneca806
University College, London222

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom18
Cancer and Haematology Centre, Churchill HospitalOxfordUnited Kingdom1
Clatterbridge Cancer CentreMetropolitan Borough of WirralUnited Kingdom10
Derriford HospitalPlymouthUnited Kingdom27
Norfolk and Norwich University HospitalNorwichUnited Kingdom11
Royal Cornwall HospitalTruroUnited Kingdom15
Royal Stoke HospitalStoke-on-TrentUnited Kingdom1
St. Bartholomew's HospitalLondonUnited Kingdom5
The Christie HospitalManchesterUnited Kingdom13
The Royal Bournemouth HospitalBournemouthUnited Kingdom1
University College London HospitalLondonUnited Kingdom32
University Hospital of WalesCardiffUnited Kingdom25